Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Shilpa Medicare LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:530549NSE Symbol: SHILPAMEDP/E(TTM):104.06
ISIN Demat:INE790G01031Div & Yield %:0EPS(TTM):6.21
Book Value(Rs):275.2371305Market Cap ( Cr.):6319.25Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 309.79247.70356.95257.05805.97663.88
Excise Duty0.000.000.000.000.000.00
Net Sales309.79247.70356.95257.05805.97663.88
Other Income 89.12175.32170.50204.4936.7941.73
Stock Adjustments -2.63-4.083.1810.2614.269.92
Total Income396.28418.94530.63471.80857.02715.53
EXPENDITURE :      
Raw Materials 86.6278.1281.9669.37279.83244.80
Power & Fuel Cost18.7318.7017.4712.4235.3131.39
Employee Cost 103.64109.54110.5776.10149.28124.66
Other Manufacturing Expenses 15.3218.2822.7916.7135.9434.12
Selling and Administration Expenses 49.7460.03106.2255.9267.0239.32
Miscellaneous Expenses 17.2618.50-0.573.4312.5042.60
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure291.31303.17338.44233.95579.87516.87
Operating Profit104.96115.78192.18237.86277.15198.66
Interest 17.2620.839.056.074.332.79
Gross Profit87.7094.95183.13231.79272.82195.87
Depreciation49.6146.5534.8222.2834.9634.01
Profit Before Tax38.0948.40148.31209.51237.86161.86
Tax11.29-8.374.8015.7839.0940.50
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.13-0.432.539.345.05-2.76
Reported Net Profit26.9457.19140.99184.39193.72124.11
Extraordinary Items -6.93-15.868.2346.40-3.656.89
Adjusted Net Profit33.8773.05132.76137.99197.37117.22
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward1332.111284.461152.44968.05794.97670.87
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.009.558.970.0020.640.00
P & L Balance carried down1359.051332.111284.461152.44968.05794.97
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.00110.00110.00110.00100.00
Earnings Per Share-Unit Curr3.106.5916.2422.6223.7615.22
Earnings Per Share(Adj)-Unit Curr3.106.5916.2422.6223.7615.22
Book Value-Unit Curr246.85243.96237.97200.89178.27157.19